aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Mar 26, 2020 · 10-K · 86 days after period end · 0001564590-20-013208
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Net Income | -$5.97M | -$6.32M | -$11.47M | -$12.57M |
| EPS Diluted | -$1.54 | -$2.92 | -$0.39 | -$0.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 26, 2020 · 86 d after period end
